GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a substantial development in how we treat diabetes mellitus . These new medications work by mimicking the body’s own GLP-1 hormone , which supports insulin release and diminishes blood sugar production . Beyond glucose control , research indicate that GLP-1 medications may also provide